Case Study

Optimize The Formulation For A Monoclonal Antibody

monoclonal-antibody-Getty--824641956

An emerging biotech company sought help developing a formulation for a monoclonal antibody. The company didn’t have in-house development expertise and wanted a partner capable of delivering an optimized formulation of buffers and excipients within an aggressive timeline and budget. As with all formulations, it was essential that the buffers and excipients selected ensured the stability of the drug substance, were compatible with each other, and met regulatory requirements. Explore how MilliporeSigma delivered an optimized formulation for this customer in three months.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development